China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a report released on Thursday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Performance

Shares of CPHI stock opened at $0.20 on Thursday. China Pharma has a 12-month low of $0.13 and a 12-month high of $0.44. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. The firm has a fifty day moving average of $0.22 and a 200-day moving average of $0.21.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.